FDA — authorised 6 June 1984
- Application: ANDA088250
- Marketing authorisation holder: SALIX PHARMS
- Status: supplemented
FDA authorised Anusol on 6 June 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 6 June 1984; FDA has authorised it.
SALIX PHARMS holds the US marketing authorisation.